Copyright © 2011 UpStart Ventures  |  All rights reserved  |  Terms of Use  &  Privacy PolicyLegal_%26_Privacy.htmlshapeimage_2_link_0
  SEND US YOUR BUSINESS PLANSend_Us_a_Business_Plan.htmlshapeimage_3_link_0
Our Strategy | Introduction

UpStart’s strategy is based on a history of successful investments by its principals, including major public and private exits. We launch and invest primarily in early-stage healthcare companies with disruptive, market-shifting technologies. Our investment strategy represents a unique combination of idea generation, science discovery, seed-stage investing, venture judgment and company management.



Investing in seed and early-stage healthcare

Our first fund, UpStart Life Sciences Capital, L.P. invests primarily in seed and early-stage healthcare companies, based on breakthrough technologies from major research universities, centered around Utah and neighboring states.

We invest in opportunities such as medical devices, drug delivery systems, and diagnostics, as well as longer range investments in biopharma products and platforms.


Central to our strategy is the belief that significantly more value can be created from the formation and initial management of leading edge life science companies than from traditional venture capital investing in pre-existing companies, whether at early or later stages.


FOCUS » Sector         FOCUS » Stage         FOCUS » Regional

 
  Five value drivers

LOCATE THE RIGHT SCIENCE & TECHNOLOGY

  1. Our team has immense experience in sourcing technology with commercial promise and untapped pockets of world-class research within leading regional academic institutions.


PARTNER WITH LEADING ACADEMICS

  1. We look for motivated scientific co-founders with ambition and integrity, who care not only for the commercial potential of their science but also have the motivation to bring it to the marketplace expeditiously and to advance the treatment of disease.


INCUBATE & MAINTAIN CASH EFFICIENCY

  1. UpStart looks to keep investments in the lab rather than spinning out, and it leverages its team’s executive management experience to minimize seed-stage hiring costs.


SOURCE NON-DILUTIVE CAPITAL

  1. We have years of experience in obtaining financial grants to fund investments


TECHNOLOGY COMPANY GROWTH & EXIT EXPERTISE

  1. Since 1985, our team members have organized, financed, and operated 14 healthcare and life science start-up companies, and collectively possess more than 70 years of experience in the formation, funding and management of such companies.

 
 
 ABOUT UPSTART    |    OUR STRATEGY    |   PORTFOLIO   |    TEAM     |    CONTACT USAbout_UpStart.htmlPortfolio.htmlOur_Team___General_Partners.htmlContact_Us.htmlshapeimage_13_link_0shapeimage_13_link_1shapeimage_13_link_2shapeimage_13_link_3shapeimage_13_link_4
Home   |   LP Login   |   News & Press   |   Careers at UpStartUpStart_Ventures____Welcome.htmlContact_Us.htmlNews_%26_Press.htmlContact_Us.htmlshapeimage_14_link_0shapeimage_14_link_1shapeimage_14_link_2shapeimage_14_link_3